Jason Cole Insider Profile
4 Followers
Jason Cole, former Chief Strategy & Financial Off at Bluebird Bio, holds 189.55K shares in Bluebird Bio (Ticker: BLUE), holds 15.09K shares in Epirus Biopharma (Ticker: EPRSQ). Most recently, Jason Cole Sold ― shares of Bluebird Bio on Aug 23, 2022 for an estimated value of $78.35K.
Jason Cole's Trading History
| BLUEBluebird Bio | Aug 23, 2022 | ― | Informative Sell | 78.35K | $942.04K | |
| EPRSQEpirus Biopharma | Jan 31, 2012 | ― | Uninformative Sell | 2.64K | $7.54K |
You May Also Like
Jason Cole insider profile FAQ
What is the percentage of profitable transactions made by Jason Cole?
The percentage of profitable transactions made by Jason Cole is 90%.
What is the average return per transaction made by Jason Cole?
The average return per transaction made by Jason Cole is 42.70%.
What stocks does Jason Cole hold?
Jason Cole holds: BLUE, EPRSQ stocks.
What was Jason Cole’s latest transaction?
Jason Cole’s latest transaction was an Informative Sell of $78.35K.
What was Jason Cole's most profitable transaction?
Jason Cole’s most profitable transaction was an Informative Sell of BLUE stock on May 5, 2021. The return on the trade was 78.50%.
What is Jason Cole's role in Bluebird Bio?
Jason Cole's role in Bluebird Bio is Chief Strategy & Financial Off.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
